Burim Sermaxhaj
Papers
1
Total Citations
2
H-Index
1
About
Burim Sermaxhaj is a dedicated researcher in the field of medical physics and radiation oncology, with a specialized focus on stereotactic radiosurgery and radiotherapy techniques. His primary research areas include the optimization of treatment planning systems, dose analysis for advanced collimation technologies, and the comparative evaluation of robotic radiosurgery platforms. Sermaxhaj’s major contribution lies in his pioneering work on the InCise 2 multi-leaf collimator (MLC) for the CyberKnife system, where he systematically compared its performance against the traditional IRIS collimator. In his highly cited 2019 study, he demonstrated that InCise 2 MLC provides superior dose conformity and target coverage for both brain and liver tumors, while reducing treatment delivery times—a critical advancement for patient comfort and clinical efficiency. Although his work has garnered modest citation counts to date, its practical implications for improving radiosurgery precision are significant. Sermaxhaj’s research bridges the gap between engineering innovation and clinical application, offering valuable insights for medical physicists and radiation oncologists seeking to enhance treatment outcomes in stereotactic radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1